HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jami McLaughlin Selected Research

Phosphotransferases (Kinase)

12/2007Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jami McLaughlin Research Topics

Disease

10Neoplasms (Cancer)
04/2024 - 12/2007
2Melanoma (Melanoma, Malignant)
01/2019 - 05/2015
1Prostatic Neoplasms (Prostate Cancer)
01/2023
1Common Cold
12/2021
1Testicular Neoplasms (Testicular Cancer)
11/2018
1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
01/2017
1Genomic Instability
01/2014
1Ataxia Telangiectasia (Louis Bar Syndrome)
01/2014
1Leukemia
12/2007
1Lymphoid Leukemia
12/2007
1Ovarian Neoplasms (Ovarian Cancer)
02/2005

Drug/Important Bio-Agent (IBA)

3EpitopesIBA
04/2024 - 11/2018
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 05/2015
3AntigensIBA
01/2022 - 05/2015
1Viral AntigensIBA
04/2024
1RNA (Ribonucleic Acid)IBA
01/2023
1RNA Precursors (Precursor, mRNA)IBA
01/2023
1prostatic acid phosphataseIBA
01/2022
1Peptides (Polypeptides)IBA
01/2022
1Cancer VaccinesIBA
01/2019
1Neoplasm Antigens (Tumor Antigens)IBA
11/2018
1ChromatinIBA
01/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1Biomarkers (Surrogate Marker)IBA
01/2014
1DeoxyribonucleosidesIBA
01/2014
1Serine (L-Serine)FDA Link
01/2014
1EnzymesIBA
12/2007
1Phosphotransferases (Kinase)IBA
12/2007
1Messenger RNA (mRNA)IBA
12/2007
1Transcription Factors (Transcription Factor)IBA
12/2007
1Tyrosine (L-Tyrosine)FDA Link
12/2007
1MicroRNAs (MicroRNA)IBA
12/2007
1LipidsIBA
02/2005
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
02/2005

Therapy/Procedure

4Immunotherapy
01/2023 - 05/2015
4Therapeutics
10/2019 - 12/2007